246 related articles for article (PubMed ID: 28775099)
1. Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS.
Blumhagen RZ; Hedin BR; Malcolm KC; Burnham EL; Moss M; Abraham E; Huie TJ; Nick JA; Fingerlin TE; Alper S
Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L930-L939. PubMed ID: 28775099
[TBL] [Abstract][Full Text] [Related]
2. NF-κB mediates lipopolysaccharide-induced alternative pre-mRNA splicing of
Lee FF; Davidson K; Harris C; McClendon J; Janssen WJ; Alper S
J Biol Chem; 2020 May; 295(18):6236-6248. PubMed ID: 32179652
[TBL] [Abstract][Full Text] [Related]
3. Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling.
Lee FFY; Alper S
Front Immunol; 2022; 13():1023567. PubMed ID: 36531997
[TBL] [Abstract][Full Text] [Related]
4. RNA Binding Proteins that Mediate LPS-induced Alternative Splicing of the MyD88 Innate Immune Regulator.
Lee FFY; Harris C; Alper S
J Mol Biol; 2024 Apr; 436(8):168497. PubMed ID: 38369277
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors: dysregulation in vivo in patients with acute respiratory distress syndrome.
Ramírez Cruz NE; Maldonado Bernal C; Cuevas Urióstegui ML; Castañoń J; López Macías C; Isibasi A
Rev Alerg Mex; 2004; 51(6):210-7. PubMed ID: 15794413
[TBL] [Abstract][Full Text] [Related]
6. Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing.
De Arras L; Alper S
PLoS Genet; 2013 Oct; 9(10):e1003855. PubMed ID: 24204290
[TBL] [Abstract][Full Text] [Related]
7. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.
Rao N; Nguyen S; Ngo K; Fung-Leung WP
Mol Cell Biol; 2005 Aug; 25(15):6521-32. PubMed ID: 16024789
[TBL] [Abstract][Full Text] [Related]
8. Regulation of toll-like receptor signaling by the SF3a mRNA splicing complex.
O'Connor BP; Danhorn T; De Arras L; Flatley BR; Marcus RA; Farias-Hesson E; Leach SM; Alper S
PLoS Genet; 2015 Feb; 11(2):e1004932. PubMed ID: 25658809
[TBL] [Abstract][Full Text] [Related]
9. Rational design of peptide derivatives for inhibition of MyD88-mediated toll-like receptor signaling in human peripheral blood mononuclear cells and epithelial cells exposed to Francisella tularensis.
Ryan DA; Degardin M; Alam S; Kissner TL; Hale M; Cameron MD; Rebek M; Ajami D; Saikh KU; Rebek J
Chem Biol Drug Des; 2017 Dec; 90(6):1190-1205. PubMed ID: 28599094
[TBL] [Abstract][Full Text] [Related]
10. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
Hung YY; Lin CC; Kang HY; Huang TL
Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
[TBL] [Abstract][Full Text] [Related]
11. Absence of Non-Canonical, Inhibitory
Cardona Gloria Y; Bernhart SH; Fillinger S; Wolz OO; Dickhöfer S; Admard J; Ossowski S; Nahnsen S; Siebert R; Weber ANR
Front Immunol; 2021; 12():616451. PubMed ID: 34163463
[TBL] [Abstract][Full Text] [Related]
12. Modification of MyD88 mRNA splicing and inhibition of IL-1beta signaling in cell culture and in mice with a 2'-O-methoxyethyl-modified oligonucleotide.
Vickers TA; Zhang H; Graham MJ; Lemonidis KM; Zhao C; Dean NM
J Immunol; 2006 Mar; 176(6):3652-61. PubMed ID: 16517734
[TBL] [Abstract][Full Text] [Related]
13. [Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yang WG
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):49-54. PubMed ID: 18353240
[TBL] [Abstract][Full Text] [Related]
14. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
15. The adapter proteins of TLRs, TRIF and MYD88, are upregulated in depressed individuals.
Hajebrahimi B; Bagheri M; Hassanshahi G; Nazari M; Bidaki R; Khodadadi H; Arababadi MK; Kennedy D
Int J Psychiatry Clin Pract; 2014 Jan; 18(1):41-4. PubMed ID: 24168294
[TBL] [Abstract][Full Text] [Related]
16. FADD negatively regulates lipopolysaccharide signaling by impairing interleukin-1 receptor-associated kinase 1-MyD88 interaction.
Zhande R; Dauphinee SM; Thomas JA; Yamamoto M; Akira S; Karsan A
Mol Cell Biol; 2007 Nov; 27(21):7394-404. PubMed ID: 17785432
[TBL] [Abstract][Full Text] [Related]
17. Roles and mechanisms of alternative splicing in cancer - implications for care.
Bonnal SC; López-Oreja I; Valcárcel J
Nat Rev Clin Oncol; 2020 Aug; 17(8):457-474. PubMed ID: 32303702
[TBL] [Abstract][Full Text] [Related]
18. p300 promotes differentiation of Th17 cells via positive regulation of the nuclear transcription factor RORγt in acute respiratory distress syndrome.
Chen Y; Wang D; Zhao Y; Huang B; Cao H; Qi D
Immunol Lett; 2018 Oct; 202():8-15. PubMed ID: 30009847
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effects of polysaccharopeptide (PSP) in human PBMC through regulation of TRAF6/TLR immunosignal-transduction pathways.
Li W; Liu M; Lai S; Xu C; Lu F; Xiao X; Bao Y
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):576-84. PubMed ID: 20131955
[TBL] [Abstract][Full Text] [Related]
20. Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barré syndrome.
Wang YZ; Liang QH; Ramkalawan H; Wang YL; Yang YF; Zhou WB; Tian FF; Li J; Yang H
Neuroimmunomodulation; 2012; 19(1):60-8. PubMed ID: 22067623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
